Web Results

en.wikipedia.org/wiki/Tositumomab

Tositumomab is a murine IgG2a lambda monoclonal antibody directed against the CD20 antigen, produced in mammalian cells. Combined with radioisotope ...

www.cancer.gov/about-cancer/treatment/drugs/fda-tositumomab-I131iodine-tositumomab

Nov 17, 2014 ... Information from the FDA about the approval of Tositumomab and Iodine I 131 Tositumomab and the clinical trials that led to the approval.

www.cancer.gov/about-cancer/treatment/drugs/tositumomab-I131tositumomab

Feb 28, 2008 ... This page contains brief information about tositumomab and iodine I 131 tositumomab and a collection of links to more information about the ...

chemocare.com/chemotherapy/drug-info/Tositumomab.aspx

Tositumomab (Bexxar) monoclonal antibody therapy side effects, how it's given, how it works, precautions and self care tips for treatment of non-hodgkin's ...

www.rxlist.com/bexxar-drug.htm

Sep 27, 2012 ... Learn about Bexxar (Tositumomab and Iodine 1131 Tositumomab) may treat, uses, dosage, side effects, drug interactions, warnings, patient ...

us.gsk.com/en-us/media/press-releases/2013/gsk-to-discontinue-manufacture-and-sale-of-the-bexxar-therapeutic-regimen-tositumomab-and-iodine-i-131-tositumomab

Aug 13, 2013 ... The BEXXAR therapeutic regimen (tositumomab and iodine I 131 tositumomab) is indicated for the treatment of patients with CD20-positive ...

ca.gsk.com/en-ca/media/press-releases/2013/sk-to-discontinue-manufacture-and-sale-of-the-bexxar-therapeutic-regimen-tositumomab-and-iodine-i-131-tositumomab

Aug 7, 2013 ... GSK to discontinue manufacture and sale of the BEXXAR® Therapeutic Regimen (tositumomab and iodine I 131 tositumomab). 07 August ...

www.ncbi.nlm.nih.gov/pubmed/12899647

Iodine-131 tositumomab [B1, Bexxar , iodine-131 anti-B1 antibody] is a murine antibody conjugated to iodine 131 that recognises and binds to the B1 (CD20) ...

www.accessdata.fda.gov/drugsatfda_docs/label/2012/125011s0126lbl.pdf

BEXXAR (tositumomab and Iodine I 131 tositumomab) is a CD20-directed radiotherapeutic antibody indicated for the treatment of patients with CD20 positive ...